Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 310M | 311M | 291M | 270M | 282M | 277M |
| Cost of revenue | 170M | 176M | 163M | 159M | 160M | 162M |
| Gross profit | 140M | 135M | 128M | 111M | 122M | 114M |
| Research and development | 22M | 24M | 22M | 21M | 21M | 21M |
| Selling, general and administrative | 102M | 102M | 98M | 102M | 94M | 90M |
| Operating expenses | 124M | 126M | 120M | 123M | 116M | 111M |
| Operating income | 17M | 8M | 8M | −12M | 7M | 3M |
| Pre-tax income | 17M | 10M | 10M | −10M | 12M | 8M |
| Income tax | 6M | 4M | 5M | −3M | 3M | 4M |
| Net income | 11M | 5M | 6M | −7M | 9M | 4M |
| Earnings per share | 0.25 | 0.12 | 0.12 | −0.15 | 0.19 | 0.08 |
| Earnings per share, diluted | 0.25 | 0.12 | 0.12 | −0.15 | 0.19 | 0.08 |
| Weighted average shares | 45M | 46M | 47M | 47M | 46M | 46M |
| Weighted average shares, diluted | 46M | 46M | 47M | 47M | 46M | 46M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 239M | 197M | 180M | 399M | 387M | 369M | 571M | 557M |
| Receivables | 250M | 217M | 246M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 55M | — | — | 26M | — | — |
| Depreciation and amortisation | 19M | 19M | 20M | 20M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 233M |
| 252M |
| 256M |
| 252M |
| 241M |
| Inventory | 99M | 101M | 107M | 106M | 91M | 89M | 95M | 93M |
| Current assets | 722M | 680M | 660M | 845M | 840M | 815M | 1.01B | 996M |
| Property, plant and equipment | 122M | 120M | 120M | 119M | 116M | 113M | 112M | 111M |
| Goodwill | 737M | 738M | 738M | 738M | 736M | 735M | 737M | 735M |
| Total assets | 2.00B | 1.97B | 1.95B | 2.15B | 2.15B | 2.12B | 2.30B | 2.29B |
| Current liabilities | 483M | 477M | 457M | 594M | 608M | 596M | 962M | 407M |
| Total liabilities | 747M | 743M | 728M | 882M | 894M | 878M | 1.07B | 1.09B |
| Equity | 1.26B | 1.23B | 1.22B | 1.26B | 1.26B | 1.24B | 1.23B | 1.20B |
| Shares outstanding | 45M | 45M | 45M | 46M | 47M | 46M | 46M | 46M |
| Shares issued | 58M | 58M | 58M | 57M | 57M | 57M | 57M | 56M |
| Treasury shares | 13M | 13M | 13M | 11M | 10M | 10M | 10M | 10M |
| 20M |
| 21M |
| Share-based compensation | 9M | — | — | 11M | — | — |
| Capital expenditure | 12M | — | — | 11M | — | — |
| Investing cash flow | −16M | — | — | −16M | — | — |
| Financing cash flow | 2M | — | — | 4M | — | — |